Related Experiment Video
Updated: May 31, 2026
14:39
Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells
Published on: April 28, 2026
[Cholinesterases: structure, role, and inhibition]
Anita Bosak1, Maja Katalinić, Zrinka Kovarik
1Institut za medicinska istraživanja i medicinu rada, Zagreb, Hrvatska.
Arhiv Za Higijenu Rada I Toksikologiju
|June 28, 2011
Summary
This study reviews cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), examining their interactions with ligands and inhibitors. It identifies key amino acids in their active sites responsible for these crucial biological interactions.
Area of Science:
- Biochemistry
- Toxicology
- Pharmacology
Background:
- Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are critical enzymes in biological systems.
- Despite structural homology, AChE and BChE exhibit distinct catalytic activities, substrate specificities, and ligand binding selectivities.
- These enzymes play significant roles in biomedicine and toxicology.
Purpose of the Study:
- To compile and review existing research on cholinesterases.
- To analyze the interactions between cholinesterases, ligands, and inhibitors.
- To identify specific amino acids within the active sites of AChE and BChE involved in these interactions.
Main Methods:
- Literature review and data compilation.
- Analysis of enzyme kinetics and binding assays.
- Structure-activity relationship studies.
Main Results:
- Cholinesterases exhibit varied substrate preferences and inhibitor sensitivities.
- Specific amino acid residues in the active sites are crucial for ligand and inhibitor binding.
- Differences in active site composition explain the distinct properties of AChE and BChE.
Conclusions:
- Understanding cholinesterase-ligand interactions is vital for drug development and toxicological assessments.
- The identified active site amino acids provide targets for designing selective inhibitors.
- Further research into cholinesterase mechanisms can lead to novel therapeutic strategies.
Related Concept Videos
01:22Cholinesterases: Distribution and Function
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...